Skip to main content
Erschienen in: Lung 6/2003

01.12.2003

Ventricular Arrhythmias and Autonomic Profile in Patients with Primary Pulmonary Hypertension

verfasst von: A. F. Folino, F. Bobbo, C. Schiraldi, F. Tona, S. Romano, G. Buja, F. Bellotto

Erschienen in: Lung | Ausgabe 6/2003

Einloggen, um Zugang zu erhalten

Abstract

The aim of our study was to assess the arrhythmic profile in patients with primary pulmonary hypertension (PPH) and its correlation with autonomic features, echocardiographic indexes and pulmonary function. We studied 9 subjects with a mean age of 42 ± 11 years. All underwent echocardiography, 24-hour Holter monitoring, and cardiopulmonary exercise testing. Left ventricle ejection fraction was normal (65 ± 6%). The right ventricle end diastolic volume was increased (108 ± 32 ml/m2) with a slight reduction of ejection fraction (49 ± 5%). Right ventricle systolic pressure was increased (91 ± 25 mmHg). Heart rate variability analysis showed evidence of a reduced standard deviation of all NN intervals (SDNN) compared with the control group (102.8 ± 32 versus 156.1 ± 32, p < 0.005). Patients with significant ventricular arrhythmias had a lower SDNN, and lower baseline and effort PO2 (SDNN: 87.0 ± 15 versus 115.4 ± 38; baseline PO2: 63.2 ± 12% versus 78.8 ± 7%; effort PO2: 50.7 ± 13% versus 68.7 ± 19%). The patients with SDNN lower than 90 ms were characterized by a higher right ventricle systolic pressure (115.0 ± 22.9 mmHg versus 79.2 ± 17.8 mmHg, p = 0.035). The patients who experienced syncope had higher SDNN (131.7 ± 36 versus 88.4 ± 20, p < 0.05), higher effort PO2 (77.5 ± 14 mmHg versus 52.3 ± 14 mmHg, p < 0.03). The patients with PPH evidenced an increased sympathetic activity. Premature ventricular beats were more frequent in those subjects with higher adrenergic drive and lower oxygen saturation. Patients with episodes of syncope seem to have a relatively higher vagal activity, and effective mechanisms of adjustment in blood oxygenation during effort.
Literatur
1.
Zurück zum Zitat D’Alonzo, GE, Barst, RJ, Ayres, SM, et al. 1991Survival in patients with primary pulmonary hypertension: results from a national prospective registry.Ann Intern Med115343349PubMed D’Alonzo, GE, Barst, RJ, Ayres, SM,  et al. 1991Survival in patients with primary pulmonary hypertension: results from a national prospective registry.Ann Intern Med115343349PubMed
2.
Zurück zum Zitat Ewert, R, Wensel, R, Opitz, CF 2003Aerosolized iloprost for primary pulmonary hypertension.N Engl J Med34314211422CrossRef Ewert, R, Wensel, R, Opitz, CF 2003Aerosolized iloprost for primary pulmonary hypertension.N Engl J Med34314211422CrossRef
3.
Zurück zum Zitat Fuster, V, Steele, PM, Edwards, WD, et al. 1984Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation70580587PubMed Fuster, V, Steele, PM, Edwards, WD,  et al. 1984Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation70580587PubMed
4.
Zurück zum Zitat Gomez, A, Bialostozky, D, Zajarias, A, et al. 2001Right ventricular ischemia in patients with primary pulmonary hypertension.Am Coll Cardiol3811371142CrossRef Gomez, A, Bialostozky, D, Zajarias, A,  et al. 2001Right ventricular ischemia in patients with primary pulmonary hypertension.Am Coll Cardiol3811371142CrossRef
5.
Zurück zum Zitat Klitzke, AK, Criee, CP, Bethge, KP, et al. 1990Cardiac arrhythmia in patients with chronic obstructive lung disease and therapy.Pneumologie44536537PubMed Klitzke, AK, Criee, CP, Bethge, KP,  et al. 1990Cardiac arrhythmia in patients with chronic obstructive lung disease and therapy.Pneumologie44536537PubMed
6.
Zurück zum Zitat Lazzeri, C, La Villa, G, Barletta, G, et al. 200024-hour heart rate variability in patients with vasovagal syncope.Pacing Clin Electrophysiol Apr23463468 Lazzeri, C, La Villa, G, Barletta, G,  et al. 200024-hour heart rate variability in patients with vasovagal syncope.Pacing Clin Electrophysiol Apr23463468
7.
Zurück zum Zitat Lipsitz, LA, Mietus, J, Moody, GB, et al. 1990Spectral characteristics of heart rate variability before and during postural tilt. Relations to aging and risk of syncope.Circulation8118031810PubMed Lipsitz, LA, Mietus, J, Moody, GB,  et al. 1990Spectral characteristics of heart rate variability before and during postural tilt. Relations to aging and risk of syncope.Circulation8118031810PubMed
8.
Zurück zum Zitat Marcus, ML, Doty, D, Hiratzke, L, et al. 1981Impaired coronary reserve in children with cyanotic congenital heart disease.Circulation64127129 Marcus, ML, Doty, D, Hiratzke, L,  et al. 1981Impaired coronary reserve in children with cyanotic congenital heart disease.Circulation64127129
9.
Zurück zum Zitat Marcus, JT, Vonk-Noordegraaf, A, Roeleveld, RJ, et al. 2001Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI.Chest11917611765CrossRefPubMed Marcus, JT, Vonk-Noordegraaf, A, Roeleveld, RJ,  et al. 2001Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI.Chest11917611765CrossRefPubMed
10.
Zurück zum Zitat Mizumaki, K, Fujiki, A, Tani, M, et al. 1995Left ventricular dimensions and autonomic balance during head-up tilt differ between patients with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope.J Am Coll Cardiol26164173CrossRefPubMed Mizumaki, K, Fujiki, A, Tani, M,  et al. 1995Left ventricular dimensions and autonomic balance during head-up tilt differ between patients with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope.J Am Coll Cardiol26164173CrossRefPubMed
11.
Zurück zum Zitat Naeije, R, Vachiery, JL 2001Medical therapy of pulmonary hypertension. Conventional therapy.Clin Chest Med22517527PubMed Naeije, R, Vachiery, JL 2001Medical therapy of pulmonary hypertension. Conventional therapy.Clin Chest Med22517527PubMed
12.
Zurück zum Zitat Petkov, V, Ziesche, R, Mosgoeller, W, et al. 2001Aerosolized iloprost improves pulmonary haemodinamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.Thorax56734736CrossRefPubMed Petkov, V, Ziesche, R, Mosgoeller, W,  et al. 2001Aerosolized iloprost improves pulmonary haemodinamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.Thorax56734736CrossRefPubMed
13.
Zurück zum Zitat Pruvot, E, Vesin, JM, Schlaepfer, J, et al. 1994Autonomic imbalance assessed by heart rate variability analysis in vasovagal syncope.Pacing Clin Electrophysiol1722012206PubMed Pruvot, E, Vesin, JM, Schlaepfer, J,  et al. 1994Autonomic imbalance assessed by heart rate variability analysis in vasovagal syncope.Pacing Clin Electrophysiol1722012206PubMed
14.
Zurück zum Zitat Rich, S, Dantzeker, DR, Ayers, SM, et al. 1987Primary pulmonary hypertension: a national prospective study.Ann Intern Med107216223PubMed Rich, S, Dantzeker, DR, Ayers, SM,  et al. 1987Primary pulmonary hypertension: a national prospective study.Ann Intern Med107216223PubMed
15.
Zurück zum Zitat Rubin, LJ, Badesch, DB, Burst, RJ, et al. 2002Bosentan therapy for pulmonary arterial hypertension.N Engl J Med346896903CrossRefPubMed Rubin, LJ, Badesch, DB, Burst, RJ,  et al. 2002Bosentan therapy for pulmonary arterial hypertension.N Engl J Med346896903CrossRefPubMed
16.
Zurück zum Zitat Rubin, LJ 1993Primary pulmonary hypertension.Chest104236250PubMed Rubin, LJ 1993Primary pulmonary hypertension.Chest104236250PubMed
17.
18.
Zurück zum Zitat Schenk, P, Petkov, V, Madl, C, et al. 2001Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.Chest119296300CrossRefPubMed Schenk, P, Petkov, V, Madl, C,  et al. 2001Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.Chest119296300CrossRefPubMed
19.
Zurück zum Zitat Schwartz, PJ, Zipes, DP 2000Autonomic modulation of cardiac arrhythmias.Zipes, DPJalife, J eds. Cardiac electrophysiology.W.B. SaundersPhiladelphia300 Schwartz, PJ, Zipes, DP 2000Autonomic modulation of cardiac arrhythmias.Zipes, DPJalife, J eds. Cardiac electrophysiology.W.B. SaundersPhiladelphia300
20.
Zurück zum Zitat Sun, X, Hansen, J, Oudiz, RJ, et al. 2001Exercise pathophysiology in patients with primary pulmonary hypertension.Circulation104429435PubMed Sun, X, Hansen, J, Oudiz, RJ,  et al. 2001Exercise pathophysiology in patients with primary pulmonary hypertension.Circulation104429435PubMed
21.
Zurück zum Zitat Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability:1966Standards of measurement, physiological interpretation and clinical use.Circulation9310431065 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability:1966Standards of measurement, physiological interpretation and clinical use.Circulation9310431065
22.
Zurück zum Zitat The International Primary Pulmonary Hypertension study group (IPPHS)1994.Chest1053741PubMed The International Primary Pulmonary Hypertension study group (IPPHS)1994.Chest1053741PubMed
23.
Zurück zum Zitat Theodorakis, GN, Kremastinos, DT, Avrambos, GT, et al. 1992Heart rate variability in patients with vasovagal syndrome.Pacing Clin Electrophysiol1522212225PubMed Theodorakis, GN, Kremastinos, DT, Avrambos, GT,  et al. 1992Heart rate variability in patients with vasovagal syndrome.Pacing Clin Electrophysiol1522212225PubMed
24.
Zurück zum Zitat Wilkens, H, Guth, A, Konig, J, et al. 2001Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.Circulation10412181222PubMed Wilkens, H, Guth, A, Konig, J,  et al. 2001Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.Circulation10412181222PubMed
Metadaten
Titel
Ventricular Arrhythmias and Autonomic Profile in Patients with Primary Pulmonary Hypertension
verfasst von
A. F. Folino
F. Bobbo
C. Schiraldi
F. Tona
S. Romano
G. Buja
F. Bellotto
Publikationsdatum
01.12.2003
Erschienen in
Lung / Ausgabe 6/2003
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-003-1034-x

Weitere Artikel der Ausgabe 6/2003

Lung 6/2003 Zur Ausgabe

OriginalPaper

Announcements

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.